• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    NeuroLogica Debuts Next-Generation SmartMSU with OmniTom Elite

    IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System

    Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development

    Iterative Scopes Announces IBD-Focused Scientific Advisory Board

    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Medicoil

    PTI Engineered Plastics Inc.

    Spectrum Plastics Group

    Medbio LLC

    MW Life Sciences
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model

    Digital Transformation for Quality and Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    MW Life Sciences

    K-Tube Technologies

    Medicoil

    Qosina Corp.

    Forefront Medical Technology
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Neurolief's Brain Neuromodulation Technology Cleared by FDA for Migraine Treatment

    Relivion is the only non-invasive multi-channel neuromodulation technology for the treatment of acute migraine.

    Related CONTENT
    • Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    • FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    • BD Receives 510(k) Clearance for Pristine Catheter
    • Medtronic Introduces Extended Infusion Set in Europe
    • Algorithm Can Predict Acute Kidney Injury Sooner Than Hospital Systems
    Michael Barbella, Managing Editor03.25.21
    The U.S. Food and Drug Administration (FDA) has granted clearance to Neurolief's Relivion system.

    Relivion is the first non-invasive multi-channel brain neuromodulation system for at home treatment of acute migraine, a debilitating neurological disease impacting 39 million people and resulting in 1.2 million emergency department visits annually.

    The FDA marketing clearance is based on the results of a multi-center, prospective, randomized, double-blind, placebo-controlled clinical study. Forty-six percent (46%) of the patients in the active group reached complete pain freedom compared to only 11.8 percent of patients in the control group. Seventy five percent of patients in the active group reached complete freedom of “Most Bothersome Symptom” (MBS, which is defined as either phonophobia, photophobia, or nausea), within two hours following treatment, compared to 46.7 percent in the control group. Complete freedom of migraine symptoms (freedom from pain as well as freedom from MBS) at two hours after treatment was significantly higher in the active group than in the control group (47.2 percent vs. 11.1 percent). Pain relief was also significantly higher in the active group than in the control group at two hours after treatment (60 percent vs. 37 percent). No serious adverse events were reported. Patients started using either the Relivion or a “placebo” device with lower treatment intensity, at the onset of their migraine episode for up to one hour. Patients were able to treat several migraine episodes during the course of the trial. The study, RIME, was conducted at leading clinical centers in the United States and Israel and evaluated the safety and efficacy of the device with 131 patients who met the International Classification of Headache Disorders (ICHD-3) criteria of migraine with or without aura.
     
    “The FDA clearance of the Relivion non-invasive device is an important event for those suffering from migraines, as it is the only neuromodulation technology thus far that has demonstrated statistically significant efficacy in providing complete freedom of migraine symptoms within 2 hours after treatment, in a sham-controlled clinical trial,” said Stewart J. Tepper, M.D., professor of Neurology at the Geisel School of Medicine at Dartmouth, who was the principal investigator on the pivotal international trial. “Patients will now have access to a highly effective, easy-to-use, non-invasive, and drug free therapeutic option that will help them regain control of their lives.”
     
    Relivion, which is worn as a headset, offers precise, personalized care to patients by delivering unparalleled stimulation to six branches of the occipital and trigeminal nerves via three adaptive output channels. This allows for the release of neurotransmitters in the brainstem and modulation of brain networks associated with control of pain.
     
    “This is a major milestone both for Neurolief and the migraine community. Relivion® offers a new paradigm for doctors treating migraine patients, reducing the dependence on pharmaceutical products and invasive procedures while keeping doctors informed of the patient’s progress,” said Chris Richardson, Neurolief’s board chairman. “It also demonstrates our commitment to becoming the leader in neuromodulation therapy, and allows a springboard to advance this technology in the future for other neurological and neuropsychiatric disorders.”
     
    Relivion previously received CE Mark certification, which indicates it conforms with health, safety, and environmental protection standards for products sold in Europe, as a treatment device for migraine, and is in preparation for the market launch. Last year, Relivion DP for the treatment of major depressive disorder received Breakthrough Device designation from the FDA. Neurolief plans to file the application for major depressive disorder by 2022. Other neurological and neuropsychiatric indications, including ADHD and insomnia, are also being explored.
     
    Migraine is a common neurological disease affecting 39 million men, women and children in the United States, resulting in 1.2 million emergency department visits each yeari. Causing severe throbbing or pulsing pain, migraines are headaches that are often accompanied by nausea, vomiting, mood changes, fatigue and extreme sensitivity to light, sound or smell, among other potential symptoms. Prior to a migraine attack, approximately half of all patients experience a phase called prodrome, which may include constipation, low mood or fatigue, among other symptoms, and approximately 20 percent of all patients experience an aura phaseii, which involves visual, sensory, motor or verbal disturbances that may be disabling. More than 90 percent of sufferers are unable to work or function normally during their migraine, and while most migraines last several hours, they can persist for days.
     
    Suggested For You
    Iterative Scopes Announces IBD-Focused Scientific Advisory Board Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    BD Receives 510(k) Clearance for Pristine Catheter BD Receives 510(k) Clearance for Pristine Catheter
    Medtronic Introduces Extended Infusion Set in Europe Medtronic Introduces Extended Infusion Set in Europe
    Algorithm Can Predict Acute Kidney Injury Sooner Than Hospital Systems Algorithm Can Predict Acute Kidney Injury Sooner Than Hospital Systems
    Elixir Medical Begins Study of Metallic Implant for CAD Treatment Elixir Medical Begins Study of Metallic Implant for CAD Treatment
    USPTO Issues Patent Covering Hancock Jaffe’s VenoValve USPTO Issues Patent Covering Hancock Jaffe’s VenoValve
    Digging into the Cardiac Arrhythmia Monitoring Device Market Digging into the Cardiac Arrhythmia Monitoring Device Market
    Bausch + Lomb Bausch + Lomb's ClearVisc Dispersive Ophthalmic Viscosurgical Device Approved
    Berlin Heals Berlin Heals' C-MIC Heart Failure Implant Achieves Breakthrough Device Status
    Cardiovascular Device Market Expands to Tackle Higher Disease Burden Cardiovascular Device Market Expands to Tackle Higher Disease Burden
    Home Is Where the Heart (Valve) Is Home Is Where the Heart (Valve) Is
    Biomechanical Engineer, Heal Thyself Biomechanical Engineer, Heal Thyself
    The Evolution of Chemical Characterization for Medical Devices The Evolution of Chemical Characterization for Medical Devices
    Ethicon Launches Echelon+ Stapler Ethicon Launches Echelon+ Stapler

    Related Breaking News

    • NeuroLogica Debuts Next-Generation SmartMSU with OmniTom Elite

      NeuroLogica Debuts Next-Generation SmartMSU with OmniTom Elite

      Mobile Stroke Unit includes new CT scanner and features that help EMTs improve patient care.
      Michael Barbella, Managing Editor 04.19.21

    • IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System

      IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System

      Product has three programmable firing modes for tissue sampling.
      Michael Barbella, Managing Editor 04.19.21

    • Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development

      Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development

      Projects address infant feeding development, neonatal jaundice, pediatric dysphagia, unplanned extubations, and adrenal crisis.
      Michael Barbella, Managing Editor 04.19.21


    • Iterative Scopes Announces IBD-Focused Scientific Advisory Board

      Iterative Scopes Announces IBD-Focused Scientific Advisory Board

      The governing body also will include experts in artificial intelligence.
      Michael Barbella, Managing Editor 04.16.21

    • Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal

      Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal

      Transaction is expected to foster the development of Vicarious Surgical's flagship robot and establish a foundation for long-term growth.
      Michael Barbella, Managing Editor 04.16.21

    • Diagnostics
      FDA Grants De Novo Clearance to Medtronic’s GI Genius Model

      FDA Grants De Novo Clearance to Medtronic’s GI Genius Model

      Assists physicians in detecting pre-cancerous growths, potentially addressing 19 million colonoscopies annually.
      Charles Sternberg, Assistant Editor 04.15.21


    • Acutus Medical Receives FDA Clearance of AcQCross

      Acutus Medical Receives FDA Clearance of AcQCross

      Product family targets more than 300,000 annual U.S. electrophysiology and structural heart procedures.
      Michael Barbella, Managing Editor 04.15.21

    • Thermo Fisher Scientific to Acquire PPD for $17.4 Billion

      Thermo Fisher Scientific to Acquire PPD for $17.4 Billion

      The deal establishes Thermo Fisher as a global leader in the high-growth clinical research services industry.
      Michael Barbella, Managing Editor 04.15.21

    • Portable Medical Devices Market to Reach $100 Billion by 2027

      Portable Medical Devices Market to Reach $100 Billion by 2027

      Sector to grow 8.5 percent annually over the next six years, driven by an increased awareness of overall health and fitness.
      Michael Barbella, Managing Editor 04.15.21


    • Chronic Disease
      BD Receives 510(k) Clearance for Pristine Catheter

      BD Receives 510(k) Clearance for Pristine Catheter

      The clearance was supported by clinical data from a feasibility study with favorable primary patency rates observed out to 180 days.
      Charles Sternberg, Assistant Editor 04.15.21

    • Chronic Disease
      Medtronic Introduces Extended Infusion Set in Europe

      Medtronic Introduces Extended Infusion Set in Europe

      Can be worn for up to seven days so users can safely stay on insulin pump therapy with fewer interruptions and insertions.
      Charles Sternberg, Assistant Editor 04.14.21

    • Cardiovascular | Software & IT
      BioSig Launches Software Update for PURE EP Electrophysiology Platform

      BioSig Launches Software Update for PURE EP Electrophysiology Platform

      The upgrade includes enhanced signal processing for advanced cardiac signal analysis.
      Sam Brusco, Associate Editor 04.14.21


    • Surgical
      Katena Acquires Ophthalmic Surgical Instrument Maker ASICO

      Katena Acquires Ophthalmic Surgical Instrument Maker ASICO

      Katena obtains high-quality ophthalmic surgical instruments.
      Sam Brusco, Associate Editor 04.14.21

    • Vicarious Surgical Appoints CFO and Chief Legal Officer

      Vicarious Surgical Appoints CFO and Chief Legal Officer

      William J. Kelly and June M. Morris have joined the company's executive team.
      Michael Barbella, Managing Editor 04.14.21

    • Nagarro Achieves ISO 13485 Certification

      Nagarro Achieves ISO 13485 Certification

      Company's iife sciences and healthcare business unit offers new opportunities in digital disruption and connected medical devices.
      Michael Barbella, Managing Editor 04.14.21


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Survey: Remote Patient Monitoring To Match Or Surpass In-Patient Within Five Years
    • Device Designed To Permanently Replace Failing Human Hearts
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • FDA OKs Canon Medical's One-Beat Spectral Cardiac CT
    • NeuroLogica Debuts Next-Generation SmartMSU with OmniTom Elite
    • IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System
    • Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development
    • Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress
    Coatings World

    Latest Breaking News From Coatings World

    Stahl Launches NuVera
    PPG Acquires Automotive Coatings Manufacturer Cetelon
    Jebsen & Jessen, Innospec Sign Distribution Agreement
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs Canon Medical's One-Beat Spectral Cardiac CT
    NeuroLogica Debuts Next-Generation SmartMSU with OmniTom Elite
    IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Resilience Acquires Ology Bioservices
    RDIF, Hualan Ink COVID-19 Vaccine Deal
    Kintor, Visum Enter COVID-19 Manufacturing Partnership
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Bésame Cosmetics Unveils Marilyn Monroe Collection
    Procos Opens U.S. Office
    Weekly Recap: HipDot Reese’s Makeup Collection, Cosmoprof Worldwide Bologna Postponed & More
    Happi

    Latest Breaking News From Happi

    Jergens Launches Mother’s Day Campaign
    Fragrance Creators Association Celebrates P&G Executive
    Jeen International Celebrates Its 25th Anniversary
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI reveals Eugene Singer Award winners at Virtual Spring Summit
    Monadnock Paper Mills joins SGP
    ACTEGA helps converter reach sustainability goals
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Andritz to Supply Elliptical Cylinder Pre-Needler in France
    Ahlstrom-Munksjö to be Delisted from Nasdaq Stockholm
    Radienz Living Introduces Sustainable Products
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    AgNovos Healthcare's AGN1 LOEP SV Kit Obtains IDE
    First Surgeries Completed with Globus Medical's CREO ONE Robotic Screw
    BioMagnetic Sciences Names President and CEO
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    LG Display Cuts Down CO2-eq Emissions by 3 Million Tons in 2020
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login